Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> VERTEX Latest News

JUL 03, 2015 - New York Times

A Must Read - Share

Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval

The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.

Tags: Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval,  Vertex Latest News

JUL 02, 2015 - Yahoo! News

A Must Read - Share

Vertex Pharma's lung disorder therapy wins FDA nod

Vertex Pharmaceuticals Inc's unique combination therapy for a rare lung disorder was given the green light by U.S. health regulators, extending the company's reach to the most common form of genetic mutation responsible for cystic fibrosis. Orkambi, a combination of Vertex's approved drug Kalydeco and a new compound called lumacaftor, is intended for patients aged 12 and above, the U.S. ...

Tags: Vertex Pharma's lung disorder therapy wins FDA nod,  Vertex Latest News

JUL 02, 2015 - Washington Times

A Must Read - Share

FDA clears drug for leading form of cystic fibrosis

WASHINGTON (AP) - Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. The Food and Drug Administration cleared the twice-a-day pill from Vertex Pharmaceuticals for a variation of ...

Tags: FDA clears drug for leading form of cystic fibrosis,  Vertex Latest News